iPSC Therapy platform
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
451
NCT05336409
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 24, 2023
Completion: Aug 31, 2027
NCT05768269
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Phase: N/A
Start: Apr 29, 2024
Completion: Mar 31, 2040
NCT06255028
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
Start: Feb 6, 2025
Completion: Aug 31, 2028
Loading map...